GGrantIndex
← Leaderboards

Amanda L. Lewis

University Of California, San Diego

Google Scholar ↗PubMed ↗ORCID ↗
$5,678,770
Attributed
$10,790,853
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.9M · FY2012–25
$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,790,853 · 5

By mechanism

R01$9,988,229 · 3
R21$802,624 · 2

Top collaborators

Most similar at University Of California, San Diego

Same institution · by research overlap

Others in their field

Top investigators on “Vagina”

Research focus

VaginaWomanMouse ModelPathogenGardnerella VaginalisPreventIn VitroBacterial VaginosisLactobacillusBacteriaMucous Body SubstancePathogenesisReproductiveInfectionRecurrenceGrowthEpithelial CellsSpecimenSialic AcidsEnzymesEpithelialAdverse OutcomeMolecularMicrobial

Grant awards (21)

3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis$741,331
R01 · FY2025 · AI
Roles of sialidase in G. vaginalis-host interactions during bacterial vaginosis$551,252
R01 · FY2025 · AI · contact PI
3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis$756,025
R01 · FY2024 · AI
Roles of sialidase in G. vaginalis-host interactions during bacterial vaginosis$570,002
R01 · FY2024 · AI · contact PI
3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis$767,360
R01 · FY2023 · AI
Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative Intravaginal Delivery Platforms to Treat Bacterial Vaginosis$497,404
R01 · FY2023 · AI
3D-bioprinting of sustained- and phased-release antibiotic and probiotic scaffolds to treat bacterial vaginosis$772,879
R01 · FY2022 · AI
Roles of sialidase in G. vaginalis-host interactions during bacterial vaginosis$585,517
R01 · FY2022 · AI · contact PI
Understanding the Host-Microbiome-Therapeutic Triad: Implications for Designing Alternative Intravaginal Delivery Platforms to Treat Bacterial Vaginosis$528,522
R01 · FY2022 · AI
Roles of sialidase in G. vaginalis-host interactions during bacterial vaginosis$678,346
R01 · FY2021 · AI · contact PI
Roles of vaginal bacteria in bladder exfoliation and recurrent UTI$157,350
R21 · FY2021 · AI · contact PI
Roles of sialidase in G. vaginalis-host interactions during bacterial vaginosis$656,803
R01 · FY2020 · AI · contact PI
Roles of vaginal bacteria in bladder exfoliation and recurrent UTI$235,938
R21 · FY2020 · AI · contact PI
ROLES OF SIALIDASE IN G. VAGINALIS-HOST INTERACTIONS DURING BACTERIAL VAGINOSIS$474,977
R01 · FY2019 · AI · contact PI
ROLES OF SIALIDASE IN G. VAGINALIS-HOST INTERACTIONS DURING BACTERIAL VAGINOSIS$595,718
R01 · FY2018 · AI · contact PI
ROLES OF SIALIDASE IN G. VAGINALIS-HOST INTERACTIONS DURING BACTERIAL VAGINOSIS$606,097
R01 · FY2017 · AI · contact PI
ROLES OF SIALIDASE IN G. VAGINALIS-HOST INTERACTIONS DURING BACTERIAL VAGINOSIS$573,950
R01 · FY2016 · AI · contact PI
ROLES OF SIALIDASE IN G. VAGINALIS-HOST INTERACTIONS DURING BACTERIAL VAGINOSIS$12,665
R01 · FY2016 · AI · contact PI
ROLES OF SIALIDASE IN G. VAGINALIS-HOST INTERACTIONS DURING BACTERIAL VAGINOSIS$619,381
R01 · FY2015 · AI · contact PI
ROLE OF GBS CAPSULE IN ASCENDING E. COLI UTI & UROSEPSIS IN AGED MULTIPAROUS MICE$219,336
R21 · FY2013 · DK · contact PI
ROLE OF GBS CAPSULE IN ASCENDING E. COLI UTI & UROSEPSIS IN AGED MULTIPAROUS MICE$190,000
R21 · FY2012 · DK · contact PI